Brief: Synektik Says KNF Approves Syn2bio Prospectus For Spin-Off
12/03/2026 16:05
March 12 (Reuters) - Synektik SA SNTP.WA: POLAND'S KNF APPROVES SYN2BIO PROSPECTUS FOR SPIN-OFF FROM COMPANY SAYS SYN2BIO DEBUT ON WARSAW STOCK EXCHANGED PLANNED FOR AROUND APRIL 16 Further company coverage: SNTP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Synektik SA
See all newsBrief: Synektik Signs Contracts For Ct And Mri Systems Worth 22.5 Mln Zlotys Net
Brief: Synektik Signs Max 10.5 Mln Zloty Deal For Supply Of Da Vinci System Consumables With Krakow University Hospital
Brief: Synektik Signs Deal With Private Company In Slovakia For Sale And Installation Of Vinci 5 System
Brief: Synektik Signs 16.1 Mln Zloty Deal To Deliver Da Vinci Robotic Surgery System To Hospital In Krakow
Brief: Synektik Q4 FY2025 Medical Equipment Orders At About 70 Mln Zlotys